Integral Ad Science (IAS) | Financial Analysis & Statements
Integral Ad Science Holding Corp. Small-cap Communication Services
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
134.1M
Gross Profit
103.9M
77.53%
Operating Income
9.5M
7.05%
Net Income
8.0M
5.96%
EPS (Diluted)
$0.05
Balance Sheet Metrics
Total Assets
1.1B
Total Liabilities
97.3M
Shareholders Equity
1.0B
Debt to Equity
0.09
Cash Flow Metrics
Operating Cash Flow
10.6M
Free Cash Flow
-7.4M
Revenue & Profitability Trend
Quarter Income Flow
Mar 31, 2025
Annual Income Flow
2024
Integral Ad Science Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 530.1M | 474.4M | 408.3M | 323.5M | 240.6M |
| Cost of Goods Sold | 114.0M | 99.4M | 75.8M | 54.6M | 40.5M |
| Gross Profit | 416.1M | 375.0M | 332.6M | 268.9M | 200.1M |
| Gross Margin % | 78.5% | 79.1% | 81.4% | 83.1% | 83.2% |
| Operating Expenses | |||||
| Research & Development | 69.9M | 72.9M | 76.4M | 67.0M | 49.0M |
| Selling, General & Administrative | 218.0M | 229.6M | 185.9M | 165.4M | 98.7M |
| Other Operating Expenses | - | - | - | 6.6M | - |
| Total Operating Expenses | 287.9M | 302.5M | 262.3M | 239.0M | 147.7M |
| Operating Income | 64.3M | 17.5M | 19.9M | -25.8M | -13.2M |
| Operating Margin % | 12.1% | 3.7% | 4.9% | -8.0% | -5.5% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 5.4M | 12.2M | 9.1M | 19.2M | 31.6M |
| Other Non-Operating Income | -3.9M | -430.0K | 2.2M | -11.0M | -636.0K |
| Pre-tax Income | 55.0M | 4.9M | 13.1M | -56.0M | -45.4M |
| Income Tax | 17.2M | -2.4M | -2.3M | -3.5M | -13.1M |
| Effective Tax Rate % | 31.3% | -49.1% | -17.5% | 0.0% | 0.0% |
| Net Income | 37.8M | 7.2M | 15.4M | -52.4M | -32.4M |
| Net Margin % | 7.1% | 1.5% | 3.8% | -16.2% | -13.5% |
| Key Metrics | |||||
| EBITDA | 128.3M | 72.5M | 77.3M | 36.5M | 52.5M |
| EPS (Basic) | $0.23 | $0.05 | $0.10 | $-0.37 | $-0.24 |
| EPS (Diluted) | $0.23 | $0.04 | $0.10 | $-0.37 | $-0.24 |
| Basic Shares Outstanding | 161060227 | 156272335 | 154699694 | 143535546 | 134044284 |
| Diluted Shares Outstanding | 161060227 | 156272335 | 154699694 | 143535546 | 134044284 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Integral Ad Science Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 84.5M | 124.8M | 86.9M | 73.2M | 51.7M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 79.4M | 74.6M | 67.9M | 53.0M | 45.4M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 36.6M | 19.0M | 24.8M | 7.6M | 4.1M |
| Total Current Assets | 254.5M | 264.9M | 221.1M | 170.2M | 129.5M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 0 | 0 | 22.8M | 0 | 0 |
| Goodwill | 1.5B | 1.6B | 1.6B | 1.6B | 1.2B |
| Intangible Assets | 194.6M | 219.2M | 241.2M | 276.4M | 255.7M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 7.6M | 6.9M | 7.0M | 5.0M | 3.6M |
| Total Non-Current Assets | 897.1M | 926.8M | 947.5M | 959.4M | 720.1M |
| Total Assets | 1.2B | 1.2B | 1.2B | 1.1B | 849.6M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 16.2M | 12.1M | 10.5M | 8.3M | 8.8M |
| Short-term Debt | 10.2M | 9.4M | 6.7M | 2.0M | 325.0K |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | 1.3M | - |
| Total Current Liabilities | 84.2M | 82.5M | 67.8M | 56.5M | 40.4M |
| Non-Current Liabilities | |||||
| Long-term Debt | 47.6M | 173.2M | 246.1M | 242.8M | 351.1M |
| Deferred Tax Liabilities | 3.1M | 20.4M | 45.5M | 53.5M | 24.8M |
| Other Non-Current Liabilities | 8.7M | 6.2M | 1.1M | 6.4M | - |
| Total Non-Current Liabilities | 59.4M | 199.8M | 292.7M | 305.9M | 377.7M |
| Total Liabilities | 143.6M | 282.3M | 360.5M | 362.3M | 418.1M |
| Equity | |||||
| Common Stock | 163.0K | 159.0K | 154.0K | 154.0K | 553.7M |
| Retained Earnings | 46.7M | 9.0M | 775.0K | -14.6M | -126.8M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.0B | 909.5M | 808.2M | 767.2M | 431.5M |
| Key Metrics | |||||
| Total Debt | 57.7M | 182.7M | 252.9M | 244.8M | 351.4M |
| Working Capital | 170.3M | 182.5M | 153.4M | 113.7M | 89.1M |
Balance Sheet Composition
Integral Ad Science Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 37.8M | 7.2M | 15.4M | -52.4M | -32.4M |
| Depreciation & Amortization | 64.0M | 55.0M | 50.4M | 62.3M | 65.7M |
| Stock-Based Compensation | 59.8M | 81.1M | 44.8M | 58.8M | 0 |
| Working Capital Changes | -12.0M | -399.0K | -20.1M | -7.0M | 7.4M |
| Operating Cash Flow | 133.5M | 121.8M | 75.1M | 60.0M | 31.3M |
| Investing Activities | |||||
| Capital Expenditures | -1.8M | -2.0M | -2.0M | -955.0K | -638.0K |
| Acquisitions | 0 | -966.0K | -1.6M | -186.4M | 0 |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -1.8M | -2.9M | -3.6M | -187.4M | -638.0K |
| Financing Activities | |||||
| Share Repurchases | 0 | 0 | -23.7M | -1.2M | -167.0K |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 0 | - | 15.0M | 245.0M | 0 |
| Debt Repayment | -120.0M | -145.0M | -36.8M | -356.7M | -1.5M |
| Financing Cash Flow | -120.0M | -70.0M | -32.3M | 404.1M | -1.7M |
| Free Cash Flow | 77.4M | 97.9M | 55.8M | 49.9M | 24.3M |
| Net Change in Cash | 11.7M | 48.9M | 39.2M | 276.7M | 28.9M |
Cash Flow Trend
Integral Ad Science Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
36.93
Forward P/E
11.49
Price to Book
1.56
Price to Sales
2.94
PEG Ratio
-0.62
Profitability Ratios
Profit Margin
7.91%
Operating Margin
9.29%
Return on Equity
4.48%
Return on Assets
3.70%
Financial Health
Current Ratio
4.43
Debt to Equity
2.24
Beta
1.57
Per Share Data
EPS (TTM)
$0.28
Book Value per Share
$6.62
Revenue per Share
$3.59
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| IAS | 1.7B | 36.93 | 1.56 | 4.48% | 7.91% | 2.24 |
| Applovin | 153.2B | 48.08 | 76.66 | 212.95% | 60.83% | 171.80 |
| Omnicom | 23.8B | 12.17 | 2.03 | 0.48% | -0.32% | 86.31 |
| Ziff Davis | 1.8B | 40.81 | 1.03 | 2.66% | 3.26% | 50.85 |
| Stagwell | 1.7B | 85.63 | 2.28 | 3.86% | 1.00% | 200.39 |
| Clear Channel | 1.2B | 59.26 | -0.35 | -0.59% | 1.24% | -1.91 |
Financial data is updated regularly. All figures are in the company's reporting currency.






